| Primary |
| Glaucoma |
33.7% |
| Product Used For Unknown Indication |
19.9% |
| Drug Use For Unknown Indication |
18.4% |
| Intraocular Pressure Increased |
7.2% |
| Hypertension |
3.3% |
| Ocular Hypertension |
2.4% |
| Postoperative Care |
2.1% |
| Drug Exposure During Pregnancy |
1.8% |
| Increased Intraocular Pressure |
1.8% |
| Intraocular Pressure Test |
1.8% |
| Open Angle Glaucoma |
1.5% |
| Accidental Exposure |
0.9% |
| Asthma |
0.9% |
| Anxiety |
0.6% |
| Back Pain |
0.6% |
| Cataract |
0.6% |
| Depression |
0.6% |
| Dry Eye |
0.6% |
| Essential Tremor |
0.6% |
| Eye Disorder |
0.6% |
|
| Vision Blurred |
13.9% |
| Ocular Hyperaemia |
10.1% |
| Drug Ineffective |
7.6% |
| Eye Irritation |
6.3% |
| Eye Pruritus |
6.3% |
| Dry Eye |
5.1% |
| Pyrexia |
5.1% |
| Thyroid Cancer |
5.1% |
| Vomiting |
5.1% |
| Fatigue |
3.8% |
| Intraocular Pressure Increased |
3.8% |
| Lacrimation Increased |
3.8% |
| Pallor |
3.8% |
| Skin Ulcer |
3.8% |
| Uveitis |
3.8% |
| Accidental Exposure |
2.5% |
| Amnesia |
2.5% |
| Anosmia |
2.5% |
| Apnoeic Attack |
2.5% |
| Blood Pressure Increased |
2.5% |
|
| Secondary |
| Glaucoma |
36.4% |
| Intraocular Pressure Increased |
17.2% |
| Ill-defined Disorder |
13.4% |
| Open Angle Glaucoma |
7.7% |
| Product Used For Unknown Indication |
5.5% |
| Drug Use For Unknown Indication |
4.9% |
| Energy Increased |
2.6% |
| Hypertension |
2.1% |
| Chronic Obstructive Pulmonary Disease |
1.3% |
| Diabetes Mellitus |
1.3% |
| Vision Blurred |
1.1% |
| Arthritis |
0.9% |
| Cataract |
0.8% |
| Diabetic Neuropathy |
0.8% |
| Intraocular Pressure Test Abnormal |
0.8% |
| Neuropathy Peripheral |
0.8% |
| Osteoporosis |
0.8% |
| Depression |
0.6% |
| Feeling Of Relaxation |
0.6% |
| Type 1 Diabetes Mellitus |
0.6% |
|
| Inflammation |
11.1% |
| Tinnitus |
10.4% |
| Pyrexia |
9.6% |
| Intraocular Pressure Increased |
8.1% |
| Ocular Hyperaemia |
6.7% |
| Visual Acuity Reduced |
6.7% |
| Skin Exfoliation |
5.9% |
| Drug Hypersensitivity |
5.2% |
| Vision Blurred |
5.2% |
| Thyroid Cancer |
4.4% |
| Vomiting |
3.7% |
| Eye Irritation |
3.0% |
| Somnolence |
3.0% |
| Tonsillitis |
3.0% |
| Visual Impairment |
3.0% |
| Eye Pain |
2.2% |
| Loss Of Consciousness |
2.2% |
| Surgery |
2.2% |
| Upper Limb Fracture |
2.2% |
| Withdrawal Syndrome |
2.2% |
|
| Concomitant |
| Glaucoma |
22.1% |
| Product Used For Unknown Indication |
20.5% |
| Drug Use For Unknown Indication |
14.6% |
| Hypertension |
6.4% |
| Diabetes Mellitus |
4.1% |
| Pain |
4.1% |
| Atrial Fibrillation |
3.2% |
| Blood Cholesterol Increased |
2.7% |
| Osteoporosis |
2.5% |
| Asthma |
2.4% |
| Rheumatoid Arthritis |
2.3% |
| Chronic Obstructive Pulmonary Disease |
2.1% |
| Depression |
2.1% |
| Anxiety |
1.7% |
| Gastrooesophageal Reflux Disease |
1.6% |
| Type 2 Diabetes Mellitus |
1.6% |
| Prophylaxis |
1.6% |
| Blood Pressure |
1.5% |
| Constipation |
1.4% |
| Hypothyroidism |
1.3% |
|
| Weight Decreased |
9.1% |
| Visual Acuity Reduced |
7.9% |
| Intraocular Pressure Increased |
7.2% |
| Vision Blurred |
6.7% |
| Urinary Tract Infection |
6.4% |
| Vomiting |
5.9% |
| Weight Increased |
5.9% |
| Visual Impairment |
5.7% |
| Ocular Hyperaemia |
5.4% |
| Glaucoma |
4.9% |
| Death |
4.4% |
| Myocardial Infarction |
4.4% |
| Pneumonia |
4.4% |
| Pain In Extremity |
3.7% |
| Drug Ineffective |
3.5% |
| Pain |
3.0% |
| Visual Field Defect |
3.0% |
| Wheezing |
3.0% |
| Pyrexia |
2.7% |
| Transient Ischaemic Attack |
2.7% |
|
| Interacting |
| Glaucoma |
50.0% |
| Nerve Injury |
50.0% |
|
|
